West Pharmaceutical Services (WST) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter increased from the preceding quarter but declined compared to the same quarter one year earlier. The sequential improvement reversed a multi-quarter downward trend in reported revenue.
Key takeaway
Quarter ended Jun 30, 2023 · FY2023 Q2
Revenue for the quarter increased from the preceding quarter but declined compared to the same quarter one year earlier. The sequential improvement reversed a multi-quarter downward trend in reported revenue.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$753.8M
Revenue reported for this quarter.
Quarter-over-quarter
+5.2%
Change from the immediately preceding quarter.
Year-over-year
-2.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $686.9M | -2.8% |
| Dec 31, 2022 | $708.7M | -3.0% |
| Mar 31, 2023 | $716.6M | -0.5% |
| Jun 30, 2023 | $753.8M | -2.3% |
Revenue performance
Quarterly revenue rose from the immediately preceding quarter, marking a positive sequential change. However, revenue was lower than the same quarter in the prior year.
Quarterly comparison
Compared to the prior quarter, revenue increased by a mid-single-digit percentage. Relative to the same quarter one year earlier, revenue decreased by a low-single-digit percentage.
What to watch
The filing context mentions a decline in operating results for the first six months compared to the prior year period.